Prevalent India
Health & Fitness LifeStyle

‘Mulethi’ may help alleviate aggressive symptoms of COVID-19

‘Mulethi’ may help alleviate aggressive symptoms of COVID-19

New Delhi: In an interesting development, a team of scientists at the Government of India’s Department of Biotechnology (DBT)’s National Brain Research Centre (NBRC), has identified Mulethi, a commonly used herb, as a potential source for the development of a drug against COVID-19. 

Scientists have found that an active ingredient in the root of the herb called Glycyrrhizinlowered the severity of the disease and brought down viral replication.

The finding assumes importance as there is still no specific drug to treat Covid-19 infection even while several vaccines have come up. The doctors currently manage with a few repurposed medicines.

The NBRC team started looking for a drug against Covid-19 last year. They studied Mulethi as it was known to have excellent anti-inflammatory properties. They carried out a series of experiments to check its potential against the COVID virus.

When the COVID virus infects human cells, the body’s immune system reacts by releasing a set of proteins called cytokines. In the case of a severe infection, the immune cells respond rapidly by releasing a “storm of cytokines”. Sometimes this can become uncontrolled leading to severe inflammation and fluid accumulation in lung tissues. This condition may lead to acute respiratory distress, cell death, and eventually, organ failure. 

The NBRC scientists found that glycyrrhizin molecules in Mulethi could help avoid this problem. The researchers expressed specific viral proteins in human lung epithelial cells. The proteins triggered inflammation in these cells. Treatment with glycyrrhizin cleared the inflammation. The untreated cells succumbed to inflammation.

The scientists analysed the molecule further and found that apart from inhibiting the cytokine storm, glycyrrhizin also reduces viral replication by 90%. Mulethi is widely prescribed for lung ailments, chronic fevers and respiratory tract inflammation in Ayurveda, glycyrrhizin is used in the treatment of chronic hepatitis B and C.

“Given its safety profile and tolerability, Mulethi might constitute a viable therapeutic option in patients with SARS-CoV-2 infection,” scientists said. The team is now looking for partners to carry forward the research into the preclinical stage. They have published a report on their study in Cytokine, the official journal of the International Cytokine and Interferon Society. Senior scientist ElloraSen conducted the study with her fellow researchers Pruthvi Gowda, Shruti Patrick, ShankerDatt, Rajesh Joshi, and Kumar Kumawat.

Related posts

Skkinix launches in Ahmedabad: A New Era of Natural Beauty Products by Riya Sharma Dave and Tirth Dave

Prevalent India

Lotus Organics + introduces its Hair Growth Active- Concentrate Serum

Prevalent India

“Snakes & Ladders of Life Through Mokshapatta” Offers Path to Enlightenment Through Ancient Vedic Wisdom

Prevalent India

On 25th & 26th June at Hotel Marriott, THE BENCHMARK FASHION SHOWCASE HI LIFE BRIDES in Surat

Prevalent India

The Great Mango Festival 2024 by Hanu Reddy Mango Tourism: A Memorable Celebration of Heritage and Community

Prevalent India

Limited-Time Culinary Adventure: Amritsar to Cream Centre

Prevalent India

Leave a Comment